D

DEM Biopharma, Inc.

31 employees

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical

Biotechnology

Life Science

Date founded

2022

Funding rounds raised

Total raised

$70M

from 6 investors over 6 rounds

D

DEM Biopharma, Inc. raised $70M on June 23, 2022

Investors: Astellas Venture Capital L.L.C., UTokyo Innovation Platform Co., Ltd., Longwood Fund, Insight Partners, Alta Partners and Emerson Collective